The Therapeutic Goods
Administration (TGA) has
ordered Orielton Laboratories
Pty Ltd to withdraw an internet
advertisement for Macular
Health with Saffron and publish a
retraction on its website.
The TGA Delegate reviewed
the matter and found that the
indications listed on the Australian
Register of Therapeutic Goods
did not match the advertisement,
that the advert was misleading
or likely to be misleading and
that it contained unverified and
misleading representations about a
serious disease.
The Delegate ordered Orielton to,
among other actions, withdraw any
representations that the product
was a saffron supplement to assist
sufferers of macular degeneration
and that it was based on recipes
that were thousands of years old.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Feb 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Feb 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.